Vyvgart 400 mg/20ml
As listed in the register: Vyvgart 400 mg/20ml, solution à diluer pour perfusion
400 mg/20ml ·
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Efgartigimodum alfa
- Made by
- argenx Switzerland SA
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Vyvgart est indiqué en association au traitement standard chez les patients adultes atteints de myasthénie auto-immune généralisée et présentant des anticorps anti-récepteurs de l’acétylcholine (RACh).
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
Details
| Made by | argenx Switzerland SA |
|---|---|
| Active substance | Efgartigimodum alfa |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 400 mg/20ml |
| Classification | L04AL01 · Cancer treatments and immune-system medicines |
| Dispensing (as stated by the register) | Abgabekategorie A |
| Name in the register | Vyvgart 400 mg/20ml, solution à diluer pour perfusion |
| Packs | 1 Durchstechflasche(n) |
| Zulassungsnummer | 69286 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.